Clinical trial
Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy
NCT00197301 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00197301 |
|---|---|
| Title | Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy |
| Official title | Phase 1 Study to Examine the Safety and Efficacy of a Novel Liposomal Based Intranasal Influenza Vaccine |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Vaccination |
| Enrollment | 200 |
| Start date | Oct 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 7, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: